# Entirely fictional teaching records

**S1 — Patient intake, September 21, 2026.** Maya, 54, postmenopausal, works as a school administrator. “I want enough energy to work and help my mother, and I want to stay strong. I keep getting different advice from podcasts. I can manage two short exercise sessions a week.” Reports poor sleep and fatigue. Asks about creatine and her glucose sensor. No examination findings supplied.

**S2 — Lab extract, April 10, 2025.** HbA1c 5.8%; LDL-C 146 mg/dL; hemoglobin 13.1 g/dL. This is a limited extract, not a complete panel.

**S3 — Lab extract, September 14, 2026.** HbA1c 5.7%; LDL-C 121 mg/dL; hemoglobin 13.0 g/dL. No kidney or thyroid results provided. A source omission does not mean the test was never done.

**S4 — Medication list imported September 20, 2026.** Atorvastatin 10 mg daily, vitamin D 1,000 IU daily. The record does not state when anyone last reconciled the list.

**S5 — Patient message, September 22, 2026.** “I stopped the cholesterol pill three weeks ago. I wasn't sure whether it was related to my aches. I haven't spoken with the prescriber yet.” This is a patient report, not a verified medication change or a confirmed adverse effect.

**S6 — Wearable summary, September 1–14, 2026.** Mean estimated sleep 6 hours 5 minutes; 9 of 14 nights recorded. Device-derived sleep measures are not a diagnosis. The missing five nights have no explanation in the export.

**S7 — CGM export, September 10–20, 2026.** Four readings below 70 mg/dL between 1 AM and 4 AM. No symptom log, confirmatory measurements or clinical interpretation supplied. No diabetes diagnosis or glucose-lowering medication appears in the supplied sources; neither absence proves a complete history.

**S8 — Prior visit plan, June 5, 2026.** Discuss strength training and sleep routines. Review symptoms and medication use at follow-up. No later clinician-approved plan supplied.

